Atea Pharmaceuticals, Inc.

NasdaqGS:AVIR Stock Report

Mkt Cap: US$380.6m

Atea Pharmaceuticals Past Performance

How has Atea Pharmaceuticals performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


74.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AVIR has high quality earnings.

Growing Profit Margin: AVIR's current net profit margins (18.6%) are higher than last year (11.9%).


Past Earnings Growth Analysis

Earnings Trend: AVIR's earnings have grown significantly by 74.9% per year over the past 5 years.

Accelerating Growth: AVIR's earnings growth over the past year (44.3%) is below its 5-year average (74.9% per year).

Earnings vs Industry: AVIR earnings growth over the past year (44.3%) exceeded the Pharmaceuticals industry 7%.


Return on Equity

High ROE: AVIR's Return on Equity (5.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies